Back to funds
View filing
Velan Capital Investment Management LP
hedge fundUpdated 27 days agoManaged by Velan Capital Investment Management Lp • Latest filing Q2 2026
Portfolio value
$164.2M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
99.4%
Weight of largest holdings
Annualized return
15.0%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $117.3M |
| Q2 2023 | $107.7M |
| Q3 2023 | $124M |
| Q4 2023 | $171.3M |
| Q1 2024 | $220.2M |
| Q2 2024 | $174.6M |
| Q3 2024 | $106.9M |
| Q4 2024 | $115.9M |
| Q1 2025 | $97.2M |
| Q2 2025 | $101.2M |
| Q3 2025 | $106.5M |
| Q4 2025 | $172.4M |
| Q1 2026 | $159.6M |
| Q2 2026 | $164.2M |
Top holdings
53 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | P PRAX PRAXIS PRECISION MEDICINES I | $29.7M | 88.8K | 18.10% | — |
| 2 | M MPLT MAPLIGHT THERAPEUTICS INC | $17.7M | 492.9K | 10.76% | — |
| 3 | ? N/A SUTRO BIOPHARMA INC | $17M | 512.2K | 10.36% | — |
| 4 | ? N/A IMMIX BIOPHARMA INC | $11.2M | 1.08M | 6.81% | — |
| 5 | T TARA PROTARA THERAPEUTICS INC | $10.9M | 2.84M | 6.62% | — |
| 6 | A AAVXF ABIVAX SA | $8.7M | 65.6K | 5.33% | — |
| 7 | ? N/A TENAX THERAPEUTICS INC | $8M | 550.0K | 4.87% | — |
| 8 | A AVR ANTERIS TECHNOLOGIES GLOBAL | $6.9M | 700.0K | 4.20% | — |
| 9 | ? N/A EDESA BIOTECH INC | $6.7M | 827.5K | 4.10% | — |
| 10 | A AVTX AVALO THERAPEUTICS INC | $6M | 324.5K | 3.65% | — |
| 11 | E EVMN EVOMMUNE INC | $5.9M | 446.3K | 3.61% | — |
| 12 | X XNCR XENCOR INC | $4.1M | 255.0K | 2.50% | — |
| 13 | R RZLT REZOLUTE INC | $3.9M | 750.0K | 2.38% | — |
| 14 | H HRTX HERON THERAPEUTICS INC | $3.7M | 8.75M | 2.28% | — |
| 15 | V VRCA VERRICA PHARMACEUTICALS INC | $2.9M | 471.6K | 1.76% | — |
| 16 | B BEPC C4 THERAPEUTICS INC | $2.7M | 570.0K | 1.62% | — |
| 17 | E EPRX EUPRAXIA PHARMACEUTICALS INC | $2.3M | 352.0K | 1.42% | — |
| 18 | A ADMA ADMA BIOLOGICS INC | $2.1M | 250.0K | 1.27% | — |
| 19 | ? N/A REIN THERAPEUTICS INC | $1.8M | 1.70M | 1.08% | — |
| 20 | L LYEL LYELL IMMUNOPHARMA INC | $1.5M | 105.0K | 0.90% | — |